Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983525 · ClinicalTrials.gov registry record · NA
The Effect of Gojiberry Intake (Lycium Barbarium) on Macular Function
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03983525 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 31 participants.
The verdict
NCT03983525, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Objective: To evaluate the effects of goji berry intake for three months on macular pigment ocular density (MPOD) between 45 and 65 years old. Specific Aims: Determine if goji berry intake for 90 days, 5 times per week, will: * result in favorable changes in macular pigment optical density (MPOD), as measured using heterochromatic flicker photometry (HFP), in adults aged from 45 to 65 years old. * impact the carotenoid distribution in the skin. * will change the fermentation capacity of the gut microbiota. The investigators hypothesize that the intake of 28 grams of goji berry for 90 days, 5 days per week will significantly increase MPOD after three months, compared to baseline values. In contrast, the investigators hypothesize that a dietary supplement of lutein and zeaxanthin will not alter MPOD.
Interventions
- DIETARY_SUPPLEMENT Goji berry
- DIETARY_SUPPLEMENT Lutein + zeaxanthin supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2020-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03983525
The ClinicalTrials.gov registry entry for NCT03983525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Goji berry is the first listed.
NCT03983525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03983525 about?
NCT03983525 is a clinical study titled "The Effect of Gojiberry Intake (Lycium Barbarium) on Macular Function". Objective: To evaluate the effects of goji berry intake for three months on macular pigment ocular density (MPOD) between 45 and 65 years old. Specific Aims: Determine if goji berry intake for 90 days, 5 times per week, will: * result in favorable changes in macular pigment optical density (MPOD)...
What is the current status of trial NCT03983525?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-06-10. Estimated completion is 2020-06-15.
What interventions are being tested in trial NCT03983525?
The interventions under investigation include: Goji berry (DIETARY_SUPPLEMENT), Lutein + zeaxanthin supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03983525?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.